Track doses, log side effects, hit your protein goals, and see your progress. Everything you need for Zepbound, in one app.
“I finally feel like I have a handle on everything. The protein tracking alone changed how I eat.”
Sarah, 38
“My doctor was impressed I had everything logged. Side effects, doses, weight. Made the appointment so much more productive.”
Amy, 46
7-day free trial. Cancel anytime.
AI Protein Tracking
Take a photo of your meal and Lina breaks it down. Protein, calories, and macros in seconds. On Zepbound, getting enough protein is everything. Lina makes it effortless.
Side Effect Logging
Nausea, fatigue, headaches. Zepbound side effects can be confusing. Log what you feel, when you feel it, and start spotting patterns your doctor will actually want to see.
Injection Reminders
Set reminders for your Zepbound injection day. Track which site you used, rotate properly, and keep a clean record of every dose.
Daily Insights
Not generic wellness tips. Real, clinically-reviewed content written specifically for people on Zepbound. From what to eat to how to manage plateaus.
Weight Tracking
Weight fluctuates. Lina shows you the trend, not the noise. See your progress over weeks and months, overlaid with your dose timeline so you can see what is working.
Everything Included
Zepbound (tirzepatide) represents a new class of weight management medication with dual GLP-1 and GIP receptor agonist action. In the landmark SURMOUNT-1 trial, participants on the highest dose lost an average of 21% of their body weight over 72 weeks, with more than one-third losing over 25%.
These are among the most significant weight loss results ever seen in a clinical trial for an anti-obesity medication. Zepbound works by activating both GLP-1 and GIP receptors, which work together to reduce appetite, improve insulin sensitivity, and promote fat loss.
With results this powerful, tracking your progress, managing side effects, and ensuring adequate protein intake become even more important. Lina gives you the tools to do all of that in one place.
References:
Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387(3):205-216.
Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med 2021;385(6):503-515.